Pharmacokinetics and Safety of Multiple-Dose Alpelisib in Participants with Moderate or Severe Hepatic Impairment: A Phase 1, Open-Label, Parallel Group Study

在患有中度或重度肝功能损害的受试者中，多次服用阿培利西布的药代动力学和安全性：一项 1 期、开放标签、平行组研究